Kevin Leach
Corporate Officer/Principal bij Massachusetts Institute of Technology
Profiel
Kevin Leach currently works at Massachusetts Institute of Technology, as Member.
Dr. Leach also formerly worked at Travere Therapeutics, Inc., as Senior Director-Translational Research and F-Star Therapeutics, Inc. (United States), as VP-Nonclinical & Translational Research.
Dr. Leach received his undergraduate degree from the University of Richmond.
Actieve functies van Kevin Leach
| Bedrijven | Functie | Begin |
|---|---|---|
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Eerdere bekende functies van Kevin Leach
| Bedrijven | Functie | Einde |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| SPRING BANK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Kevin Leach
| University of Richmond | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
